dantetzl – Hibiscus BioVentures

All Mayflower BioVentures

Mayo Clinic Joins With Industry Groups to Launch Biotech Accelerator

All Mayflower BioVentures

Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator

3DBio Therapeutics 3-D Printed Ear

3DBio Therapeutics All

3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

All

Innoforce and Hibiscus BioVentures Announce Strategic Partnership to Enable Development of Advanced Therapies

All

Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research

connectRN

All

connectRN raises $76M for healthcare worker staffing, networking

Hibiscus Bioventures and Cellevolve

All

Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies

Stock Market Image

All NexImmune

NexImmune Announces Pricing of Upsized Initial Public Offering

Biotech Image

All NexImmune

Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Office

All

Bayer and Northpond Ventures Lead USD 55 million Series A Financing Round for Triumvira Immunologics

© 2022 Hibiscus BioVentures.